Guardian Pharmacy Services (GRDN) Common Equity (2023 - 2026)

Guardian Pharmacy Services' Common Equity history runs 4 years deep, the most recent figure standing at $232.4 million for Q1 2026.

• In Q1 2026, Common Equity rose 42.4% year-over-year to $232.4 million; the TTM figure through Mar 2026 stood at $232.4 million (up 42.4% YoY), while the FY2025 annual figure was $217.9 million, up 45.31% from the prior year.
• Common Equity came in at $232.4 million for Q1 2026 at Guardian Pharmacy Services, up from $217.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $232.4 million in Q1 2026 to a low of $56.6 million in Q1 2024.
• A 4-year average of $136.9 million and a median of $150.0 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 214.04% in 2025 and soared 42.4% in 2026, its largest moves.
• Guardian Pharmacy Services' Common Equity stood at $59.9 million in 2023, then soared by 150.55% to $150.0 million in 2024, then jumped by 45.31% to $217.9 million in 2025, then grew by 6.65% to $232.4 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $232.4 million, $217.9 million, and $195.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison